American Vanguard Corporation (AVD) 10-Year Financial Performance & Capital Metrics

AVD • • Industrial / General

Basic MaterialsAgricultural InputsCrop Protection & ChemicalsCrop Protection Chemical Manufacturers

AboutAmerican Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.Show more

Revenue $547M -5.5%
EBITDA -$79M -275.3%
Net Income -$126M -1780.3%
EPS (Diluted) -4.50 -1830.8%
Gross Margin 21.98% -28.9%
EBITDA Margin -14.44% -285.5%
Operating Margin -18.56% -561.5%
Net Margin -23.08% -1878.7%
ROE -41.9% -2161.6%
ROIC -16.76% -553.9%
Debt/Equity 0.72 +64.3%
Interest Coverage -6.05 -428.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Healthy dividend yield of 2.1%
✓Trading at only 0.5x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 18 (bottom 18%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y6.25%

5Y3.17%

3Y-0.62%

TTM-4.29%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-287.45%

EPS CAGR

10Y-

5Y-

3Y-

TTM-285.44%

ROCE

10Y Avg3.29%

5Y Avg0.49%

3Y Avg-2.72%

Latest-21.57%

Peer Comparison

Crop Protection Chemical Manufacturers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
FMCFMC Corporation	1.93B	15.48	5.69	-5.36%	-15.05%	-14.07%	31.19%	0.78
AVDAmerican Vanguard Corporation	122.41M	4.30	-0.96	-5.53%	-21.15%	-50.73%		0.72

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	289.38M	312.11M	355.05M	454.27M	468.19M	458.7M	557.68M	609.62M	579.37M	547.31M
Revenue Growth %	-0.03%	0.08%	0.14%	0.28%	0.03%	-0.02%	0.22%	0.09%	-0.05%	-0.06%
Cost of Goods Sold+	177.48M	183.82M	207.66M	271.64M	290.83M	286.11M	386.95M	368.26M	400.21M	426.99M
COGS % of Revenue	0.61%	0.59%	0.58%	0.6%	0.62%	0.62%	0.69%	0.6%	0.69%	0.78%
Gross Profit+	111.9M	128.29M	147.39M	182.63M	177.35M	172.59M	170.72M	241.35M	179.16M	120.32M
Gross Margin %	0.39%	0.41%	0.42%	0.4%	0.38%	0.38%	0.31%	0.4%	0.31%	0.22%
Gross Profit Growth %	-0.02%	0.15%	0.15%	0.24%	-0.03%	-0.03%	-0.01%	0.41%	-0.26%	-0.33%
Operating Expenses+	100.38M	107.75M	120.6M	143.61M	151.13M	149.68M	139.78M	200.7M	155.87M	221.87M
OpEx % of Revenue	0.35%	0.35%	0.34%	0.32%	0.32%	0.33%	0.25%	0.33%	0.27%	0.41%
Selling, General & Admin	81.57M	86.45M	94.52M	117.18M	127.06M	115.28M	111.09M	154.93M	116.89M	119.63M
SG&A % of Revenue	0.28%	0.28%	0.27%	0.26%	0.27%	0.25%	0.2%	0.25%	0.2%	0.22%
Research & Development	18.81M	21.3M	26.08M	26.43M	24.07M	26.31M	28.86M	31.82M	38.02M	32.66M
R&D % of Revenue	0.06%	0.07%	0.07%	0.06%	0.05%	0.06%	0.05%	0.05%	0.07%	0.06%
Other Operating Expenses	0	0	0	0	0	8.09M	-171K	13.95M	957K	69.58M
Operating Income+	11.52M	20.54M	26.79M	39.02M	26.22M	22.91M	30.95M	40.65M	23.3M	-101.56M
Operating Margin %	0.04%	0.07%	0.08%	0.09%	0.06%	0.05%	0.06%	0.07%	0.04%	-0.19%
Operating Income Growth %	0.72%	0.78%	0.3%	0.46%	-0.33%	-0.13%	0.35%	0.31%	-0.43%	-5.36%
EBITDA+	28M	36.87M	43.75M	57.91M	44.86M	42.81M	57.12M	62.79M	45.08M	-79.01M
EBITDA Margin %	0.1%	0.12%	0.12%	0.13%	0.1%	0.09%	0.1%	0.1%	0.08%	-0.14%
EBITDA Growth %	0.22%	0.32%	0.19%	0.32%	-0.23%	-0.05%	0.33%	0.1%	-0.28%	-2.75%
D&A (Non-Cash Add-back)	16.47M	16.33M	16.96M	18.89M	18.64M	19.9M	26.17M	22.14M	21.78M	22.55M
EBIT	11.52M	20.54M	26.84M	39.02M	26.22M	23.39M	30.83M	40.65M	22.94M	-31.98M
Net Interest Income+	-2.56M	-1.62M	-1.94M	-4.02M	-7.21M	-5.18M	-3.62M	-3.95M	-12.27M	-16.55M
Interest Income	0	7K	41K	174K	182K	89K	65K	167K	368K	230K
Interest Expense	2.14M	1.63M	1.98M	4.2M	7.39M	5.27M	3.69M	4.12M	12.64M	16.78M
Other Income/Expense	-2.56M	-1.62M	-1.94M	-5.42M	-7.42M	-4.59M	-4.19M	-4.69M	-13M	-18.9M
Pretax Income+	8.96M	18.92M	24.85M	33.6M	18.8M	18.32M	26.75M	35.97M	10.3M	-120.46M
Pretax Margin %	0.03%	0.06%	0.07%	0.07%	0.04%	0.04%	0.05%	0.06%	0.02%	-0.22%
Income Tax+	2.01M	5.54M	4.44M	9.14M	5.2M	3.08M	8.17M	8.56M	2.78M	5.88M
Effective Tax Rate %	0.74%	0.68%	0.82%	0.72%	0.72%	0.83%	0.69%	0.76%	0.73%	1.05%
Net Income+	6.59M	12.79M	20.27M	24.2M	13.6M	15.24M	18.59M	27.4M	7.52M	-126.34M
Net Margin %	0.02%	0.04%	0.06%	0.05%	0.03%	0.03%	0.03%	0.04%	0.01%	-0.23%
Net Income Growth %	0.36%	0.94%	0.59%	0.19%	-0.44%	0.12%	0.22%	0.47%	-0.73%	-17.8%
Net Income (Continuing)	6.32M	13.02M	20.36M	24.06M	13.6M	15.24M	18.59M	27.4M	7.52M	-126.34M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	-69K	167K	254K	0	0	0	0	0	0	0
EPS (Diluted)+	0.23	0.44	0.68	0.81	0.46	0.51	0.61	0.92	0.26	-4.50
EPS Growth %	0.35%	0.91%	0.55%	0.19%	-0.43%	0.11%	0.2%	0.51%	-0.72%	-18.31%
EPS (Basic)	0.23	0.44	0.70	0.83	0.47	0.52	0.62	0.94	0.27	-4.50
Diluted Shares Outstanding	29.24M	29.39M	29.7M	30.05M	29.66M	29.99M	30.41M	29.87M	28.53M	28.06M
Basic Shares Outstanding	28.67M	28.86M	29.1M	29.33M	29.03M	29.45M	29.81M	29.23M	28.13M	28.06M
Dividend Payout Ratio	0.17%	0.05%	0.08%	0.09%	0.17%	0.08%	0.13%	0.1%	0.45%	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	236.83M	227.07M	254.88M	310.19M	336.2M	330.25M	342M	388.57M	432.02M	378.89M
Cash & Short-Term Investments	5.52M	7.87M	11.34M	6.17M	6.58M	15.92M	16.29M	20.33M	11.42M	12.51M
Cash Only	5.52M	7.87M	11.34M	6.17M	6.58M	15.92M	16.29M	20.33M	11.42M	12.51M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	75.39M	87.21M	109.61M	134.03M	155.85M	131.75M	158.92M	168.2M	194.79M	179.47M
Days Sales Outstanding	95.09	101.98	112.68	107.69	121.5	104.84	104.01	100.71	122.72	119.69
Inventory	136.48M	120.58M	123.12M	159.9M	163.31M	163.78M	154.31M	184.19M	219.55M	179.29M
Days Inventory Outstanding	280.67	239.41	216.42	214.85	204.96	208.94	145.55	182.56	200.24	153.26
Other Current Assets	0	0	0	0	0	8.29M	0	0	0	0
Total Non-Current Assets+	206.71M	202.88M	280.71M	283.4M	354.89M	350.04M	352.16M	337.75M	335.53M	257.83M
Property, Plant & Equipment	47.97M	50.3M	49.32M	49.25M	67.78M	77.58M	91.5M	95.16M	96.98M	77.9M
Fixed Asset Turnover	6.03x	6.21x	7.20x	9.22x	6.91x	5.91x	6.10x	6.41x	5.97x	7.03x
Goodwill	0	0	22.18M	25.79M	46.56M	52.11M	46.26M	47.01M	51.2M	19.7M
Intangible Assets	129.16M	121.43M	180.95M	186.58M	198.38M	197.51M	197.84M	184.66M	172.51M	150.5M
Long-Term Investments	-8.1M	-6.71M	-16.28M	-16.01M	0	1.91M	4.4M	0	0	0
Other Non-Current Assets	29.58M	31.15M	28.25M	21.77M	21.19M	20.93M	11.89M	10.77M	14.84M	8.48M
Total Assets+	443.54M	429.96M	535.59M	593.59M	691.09M	680.29M	694.16M	726.31M	767.55M	636.72M
Asset Turnover	0.65x	0.73x	0.66x	0.77x	0.68x	0.67x	0.80x	0.84x	0.75x	0.86x
Asset Growth %	-0.06%	-0.03%	0.25%	0.11%	0.16%	-0.02%	0.02%	0.05%	0.06%	-0.17%
Total Current Liabilities+	76.28M	97.07M	126.2M	145.53M	138.64M	171.32M	223.06M	266.6M	230.5M	232.35M
Accounts Payable	15.34M	24.36M	53.75M	66.53M	64.88M	59.25M	67.14M	69M	68.83M	69.16M
Days Payables Outstanding	31.55	48.36	94.47	89.4	81.43	75.59	63.33	68.39	62.78	59.12
Short-Term Debt	55K	0	0	0	4.9M	0	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	0	1000K	1000K	1000K	1000K
Other Current Liabilities	514K	26K	5.39M	1.61M	62.03M	46.26M	802K	0	0	0
Current Ratio	3.10x	2.34x	2.02x	2.13x	2.43x	1.93x	1.53x	1.46x	1.87x	1.63x
Quick Ratio	1.32x	1.10x	1.04x	1.03x	1.25x	0.97x	0.84x	0.77x	0.92x	0.86x
Cash Conversion Cycle	344.21	293.03	234.62	233.14	245.03	238.19	186.23	214.88	260.18	213.83
Total Non-Current Liabilities+	98.93M	50.52M	104.08M	118.83M	208.29M	148.23M	98.36M	89.73M	167.04M	171.26M
Long-Term Debt	68.32M	40.95M	77.49M	96.67M	148.77M	107.44M	52.24M	51.48M	138.9M	147.33M
Capital Lease Obligations	0	0	0	0	6.5M	8.18M	20.78M	19.49M	17.11M	14.34M
Deferred Tax Liabilities	27.56M	6.71M	16.28M	15.36M	40.13M	0	20.01M	14.6M	7.89M	7.99M
Other Non-Current Liabilities	3.05M	2.87M	10.31M	6.79M	12.89M	32.61M	5.33M	4.17M	3.14M	1.6M
Total Liabilities	175.21M	147.6M	230.28M	264.36M	346.93M	319.56M	321.42M	356.33M	397.54M	403.61M
Total Debt+	68.38M	40.95M	77.49M	96.67M	160.17M	119.81M	78.08M	76.25M	162.09M	167.81M
Net Debt	62.85M	33.08M	66.15M	90.5M	153.59M	103.88M	61.79M	55.92M	150.68M	155.29M
Debt / Equity	0.25x	0.15x	0.25x	0.29x	0.47x	0.33x	0.21x	0.21x	0.44x	0.72x
Debt / EBITDA	2.44x	1.11x	1.77x	1.67x	3.57x	2.80x	1.37x	1.21x	3.60x	-
Net Debt / EBITDA	2.24x	0.90x	1.51x	1.56x	3.42x	2.43x	1.08x	0.89x	3.34x	-
Interest Coverage	5.40x	12.60x	13.52x	9.30x	3.55x	4.35x	8.39x	9.86x	1.84x	-6.05x
Total Equity+	268.33M	282.36M	305.31M	329.23M	344.16M	360.74M	372.74M	369.98M	370.01M	233.11M
Equity Growth %	0.03%	0.05%	0.08%	0.08%	0.05%	0.05%	0.03%	-0.01%	0%	-0.37%
Book Value per Share	9.18	9.61	10.28	10.96	11.60	12.03	12.26	12.39	12.97	8.31
Total Shareholders' Equity	268.39M	282.19M	305.06M	329.23M	344.16M	360.74M	372.74M	369.98M	370.01M	233.11M
Common Stock	3.16M	3.18M	3.23M	3.28M	3.32M	3.39M	3.43M	3.44M	3.47M	3.48M
Retained Earnings	208.51M	220.43M	238.95M	262.84M	274.12M	288.18M	304.38M	328.75M	332.9M	204.88M
Treasury Stock	-8.27M	-8.27M	-8.27M	-15.56M	-18.16M	-18.16M	-22.74M	-55.66M	-71.2M	-71.2M
Accumulated OCI	-3.54M	-4.85M	-4.51M	-4.51M	-5.7M	-9.32M	-13.78M	-12.18M	-5.96M	-18.73M
Minority Interest	-69K	167K	254K	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	78.57M	46.41M	59M	11.35M	9.61M	90.32M	86.36M	57.1M	-58.75M	3.92M
Operating CF Margin %	0.27%	0.15%	0.17%	0.02%	0.02%	0.2%	0.15%	0.09%	-0.1%	0.01%
Operating CF Growth %	3.3%	-0.41%	0.27%	-0.81%	-0.15%	8.4%	-0.04%	-0.34%	-2.03%	1.07%
Net Income	6.32M	13.02M	20.36M	24.06M	13.6M	15.24M	18.59M	27.4M	7.52M	-126.34M
Depreciation & Amortization	16.47M	16.33M	16.96M	18.89M	18.64M	19.9M	26.17M	22.14M	21.78M	22.32M
Stock-Based Compensation	3.88M	3.17M	4.71M	5.8M	7.16M	6.56M	6.88M	5.68M	6.14M	4.41M
Deferred Taxes	27K	-151K	398K	-561K	2.88M	-1.12M	-3.87M	-6.72M	-10.22M	-95K
Other Non-Cash Items	6.03M	5.48M	5.38M	5.63M	1.68M	105K	2.19M	6.68M	3.98M	55.62M
Working Capital Changes	45.84M	8.56M	11.19M	-42.48M	-34.35M	49.64M	36.41M	1.92M	-87.94M	48.01M
Change in Receivables	13.03M	-11.82M	754K	-21.32M	-18.37M	15.12M	-18.3M	-11.36M	-16.71M	3.71M
Change in Inventory	29.15M	15.9M	16.18M	-31.44M	3.82M	6.68M	9.36M	-29.22M	-27.32M	35.18M
Change in Payables	-5.07M	9.02M	3.32M	9.1M	-7.91M	-8.2M	8.78M	1.7M	-2.29M	3.71M
Cash from Investing+	-43.69M	-14.14M	-89.51M	-27.7M	-54.84M	-35.8M	-20.04M	-14.47M	-17.02M	-6.62M
Capital Expenditures	-43.57M	-10.85M	-88.56M	-27.7M	-16.86M	-15.26M	-10.04M	-14.55M	-12.06M	-7.69M
CapEx % of Revenue	0.15%	0.03%	0.25%	0.06%	0.04%	0.03%	0.02%	0.02%	0.02%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-36.79M	-3.51M	-6.67M	0	0	-1.19M	0	84K	242K	1.06M
Cash from Financing+	-32.86M	-28.55M	33.94M	11.13M	46.41M	-44.44M	-65.87M	-38.26M	66.74M	4.54M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-1.14M	-578K	-1.6M	-2.2M	-2.32M	-1.17M	-2.38M	-2.79M	-3.38M	-2.51M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-1.52M	-367K	-1.49M	-73K	-170K	1.1M	-386K	1.6M	1.03M	51K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	35M	35.55M	-29.56M	-16.35M	-7.25M	75.06M	76.32M	42.55M	-70.81M	-3.77M
FCF Margin %	0.12%	0.11%	-0.08%	-0.04%	-0.02%	0.16%	0.14%	0.07%	-0.12%	-0.01%
FCF Growth %	1.85%	0.02%	-1.83%	0.45%	0.56%	11.35%	0.02%	-0.44%	-2.66%	0.95%
FCF per Share	1.20	1.21	-1.00	-0.54	-0.24	2.50	2.51	1.42	-2.48	-0.13
FCF Conversion (FCF/Net Income)	11.92x	3.63x	2.91x	0.47x	0.71x	5.93x	4.65x	2.08x	-7.81x	-0.03x
Interest Paid	2.75M	1.75M	1.5M	3.32M	7.12M	5.31M	3.52M	3.83M	11.9M	15.59M
Taxes Paid	3.7M	4.95M	17.84M	-8.45M	9.28M	3.88M	5.8M	19.96M	9.43M	8.76M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	2.49%	4.64%	6.9%	7.63%	4.04%	4.32%	5.07%	7.38%	2.03%	-41.9%
Return on Invested Capital (ROIC)	2.52%	4.76%	5.85%	7.4%	4.29%	3.57%	5.16%	7.09%	3.69%	-16.76%
Gross Margin	38.67%	41.1%	41.51%	40.2%	37.88%	37.63%	30.61%	39.59%	30.92%	21.98%
Net Margin	2.28%	4.1%	5.71%	5.33%	2.9%	3.32%	3.33%	4.5%	1.3%	-23.08%
Debt / Equity	0.25x	0.15x	0.25x	0.29x	0.47x	0.33x	0.21x	0.21x	0.44x	0.72x
Interest Coverage	5.40x	12.60x	13.52x	9.30x	3.55x	4.35x	8.39x	9.86x	1.84x	-6.05x
FCF Conversion	11.92x	3.63x	2.91x	0.47x	0.71x	5.93x	4.65x	2.08x	-7.81x	-0.03x
Revenue Growth	-3.1%	7.85%	13.76%	27.95%	3.06%	-2.03%	21.58%	9.31%	-4.96%	-5.53%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
U S Crop	-	-	-	-	-	223.17M	263.63M	288.62M	269.23M	228.33M
U S Crop Growth	-	-	-	-	-	-	18.13%	9.48%	-6.72%	-15.19%
U S Non Crop	-	-	-	-	-	48.56M	78.61M	76.71M	75.29M	82.4M
U S Non Crop Growth	-	-	-	-	-	-	61.88%	-2.41%	-1.85%	9.45%
Crop	-	-	301.41M	-	402.4M	-	-	-	-	-
Crop Growth	-	-	-	-	-	-	-	-	-	-
Amount Of Herbicides Sold	111.9M	123.54M	121.58M	-	181.69M	-	-	-	-	-
Amount Of Herbicides Sold Growth	-	10.41%	-1.59%	-	-	-	-	-	-	-
Amount Of Insecticides Sold	117.18M	119.23M	132.14M	-	153.45M	-	-	-	-	-
Amount Of Insecticides Sold Growth	-	1.75%	10.83%	-	-	-	-	-	-	-
Other Including Plant Growth Regulators	-	-	47.69M	58.36M	67.27M	-	-	-	-	-
Other Including Plant Growth Regulators Growth	-	-	-	22.37%	15.26%	-	-	-	-	-
Non Crop	-	-	53.64M	61.97M	65.79M	-	-	-	-	-
Non Crop Growth	-	-	-	15.53%	6.16%	-	-	-	-	-
All Others	-	29.44M	-	-	-	-	-	-	-	-
All Others Growth	-	-	-	-	-	-	-	-	-	-
Others	29.01M	-	-	-	-	-	-	-	-	-
Others Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Non-US	-	-	-	-	-	-	-	244.28M	234.85M	236.58M
Non-US Growth	-	-	-	-	-	-	-	-	-3.86%	0.73%
Central And South America	-	16.23M	25.75M	86.17M	111.11M	102.28M	108.97M	124.53M	117.73M	118.16M
Central And South America Growth	-	-	58.61%	234.67%	28.94%	-7.94%	6.54%	14.27%	-5.46%	0.37%
MEXICO	17.1M	16.69M	16.03M	24.58M	28.84M	33.52M	40.72M	45.99M	49.8M	48.46M
MEXICO Growth	-	-2.37%	-3.95%	53.33%	17.32%	16.24%	21.50%	12.94%	8.27%	-2.68%
Asia	13.85M	17.14M	28.88M	14.83M	15.55M	19.29M	26.23M	26.59M	28.07M	34.12M
Asia Growth	-	23.77%	68.51%	-48.66%	4.90%	24.02%	36.00%	1.35%	5.58%	21.56%
AUSTRALIA	4.16M	3.73M	4.33M	2.63M	2.8M	9.9M	20.26M	19.67M	19.71M	21.69M
AUSTRALIA Growth	-	-10.17%	16.04%	-39.20%	6.19%	253.90%	104.57%	-2.88%	0.19%	10.02%
CANADA	1.58M	3.69M	4.08M	3.4M	11.64M	10.57M	10.38M	14.86M	12.27M	8.51M
CANADA Growth	-	132.81%	10.65%	-16.65%	241.96%	-9.15%	-1.84%	43.20%	-17.44%	-30.61%
Africa	8.62M	7.11M	7.89M	8.03M	6.75M	6.07M	3.47M	8.84M	3.71M	5.65M
Africa Growth	-	-17.52%	11.00%	1.70%	-15.91%	-10.04%	-42.89%	154.90%	-57.98%	51.98%
Europe	12.35M	14.52M	10.7M	11.06M	6.89M	2.29M	2.24M	1.96M	2.21M	1.89M
Europe Growth	-	17.56%	-26.30%	3.36%	-37.71%	-66.73%	-2.14%	-12.44%	12.42%	-14.27%
Middle East	3.23M	4.04M	1.24M	3.26M	2.39M	3.05M	2.36M	1.84M	1.35M	739K
Middle East Growth	-	25.11%	-69.39%	163.22%	-26.54%	27.68%	-22.82%	-22.10%	-26.25%	-45.42%
Non Us	-	83.26M	98.91M	-	185.96M	186.98M	214.63M	-	-	-
Non Us Growth	-	-	18.79%	-	-	0.55%	14.79%	-	-	-
Other Countries	437K	101K	-	-	-	-	-	-	-	-
Other Countries Growth	-	-76.89%	-	-	-	-	-	-	-	-
Central and South America	15.97M	-	-	-	-	-	-	-	-	-
Central and South America Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

American Vanguard Corporation (AVD) reported $530.1M in revenue for fiscal year 2024. This represents a 74% increase from $304.4M in 2011.

American Vanguard Corporation (AVD) saw revenue decline by 5.5% over the past year.

American Vanguard Corporation (AVD) reported a net loss of $112.1M for fiscal year 2024.

Dividend & Returns

Yes, American Vanguard Corporation (AVD) pays a dividend with a yield of 2.08%. This makes it attractive for income-focused investors.

American Vanguard Corporation (AVD) has a return on equity (ROE) of -41.9%. Negative ROE indicates the company is unprofitable.

American Vanguard Corporation (AVD) generated $2.9M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

American Vanguard Corporation (AVD) 10-Year Financial Performance & Capital Metrics

AVD • • Industrial / General

Basic MaterialsAgricultural InputsCrop Protection & ChemicalsCrop Protection Chemical Manufacturers

Revenue $547M -5.5%
EBITDA -$79M -275.3%
Net Income -$126M -1780.3%
EPS (Diluted) -4.50 -1830.8%
Gross Margin 21.98% -28.9%
EBITDA Margin -14.44% -285.5%
Operating Margin -18.56% -561.5%
Net Margin -23.08% -1878.7%
ROE -41.9% -2161.6%
ROIC -16.76% -553.9%
Debt/Equity 0.72 +64.3%
Interest Coverage -6.05 -428.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Healthy dividend yield of 2.1%
✓Trading at only 0.5x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 18 (bottom 18%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y6.25%

5Y3.17%

3Y-0.62%

TTM-4.29%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-287.45%

EPS CAGR

10Y-

5Y-

3Y-

TTM-285.44%

ROCE

10Y Avg3.29%

5Y Avg0.49%

3Y Avg-2.72%

Latest-21.57%

Peer Comparison

Crop Protection Chemical Manufacturers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
FMCFMC Corporation	1.93B	15.48	5.69	-5.36%	-15.05%	-14.07%	31.19%	0.78
AVDAmerican Vanguard Corporation	122.41M	4.30	-0.96	-5.53%	-21.15%	-50.73%		0.72

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	289.38M	312.11M	355.05M	454.27M	468.19M	458.7M	557.68M	609.62M	579.37M	547.31M
Revenue Growth %	-0.03%	0.08%	0.14%	0.28%	0.03%	-0.02%	0.22%	0.09%	-0.05%	-0.06%
Cost of Goods Sold+	177.48M	183.82M	207.66M	271.64M	290.83M	286.11M	386.95M	368.26M	400.21M	426.99M
COGS % of Revenue	0.61%	0.59%	0.58%	0.6%	0.62%	0.62%	0.69%	0.6%	0.69%	0.78%
Gross Profit+	111.9M	128.29M	147.39M	182.63M	177.35M	172.59M	170.72M	241.35M	179.16M	120.32M
Gross Margin %	0.39%	0.41%	0.42%	0.4%	0.38%	0.38%	0.31%	0.4%	0.31%	0.22%
Gross Profit Growth %	-0.02%	0.15%	0.15%	0.24%	-0.03%	-0.03%	-0.01%	0.41%	-0.26%	-0.33%
Operating Expenses+	100.38M	107.75M	120.6M	143.61M	151.13M	149.68M	139.78M	200.7M	155.87M	221.87M
OpEx % of Revenue	0.35%	0.35%	0.34%	0.32%	0.32%	0.33%	0.25%	0.33%	0.27%	0.41%
Selling, General & Admin	81.57M	86.45M	94.52M	117.18M	127.06M	115.28M	111.09M	154.93M	116.89M	119.63M
SG&A % of Revenue	0.28%	0.28%	0.27%	0.26%	0.27%	0.25%	0.2%	0.25%	0.2%	0.22%
Research & Development	18.81M	21.3M	26.08M	26.43M	24.07M	26.31M	28.86M	31.82M	38.02M	32.66M
R&D % of Revenue	0.06%	0.07%	0.07%	0.06%	0.05%	0.06%	0.05%	0.05%	0.07%	0.06%
Other Operating Expenses	0	0	0	0	0	8.09M	-171K	13.95M	957K	69.58M
Operating Income+	11.52M	20.54M	26.79M	39.02M	26.22M	22.91M	30.95M	40.65M	23.3M	-101.56M
Operating Margin %	0.04%	0.07%	0.08%	0.09%	0.06%	0.05%	0.06%	0.07%	0.04%	-0.19%
Operating Income Growth %	0.72%	0.78%	0.3%	0.46%	-0.33%	-0.13%	0.35%	0.31%	-0.43%	-5.36%
EBITDA+	28M	36.87M	43.75M	57.91M	44.86M	42.81M	57.12M	62.79M	45.08M	-79.01M
EBITDA Margin %	0.1%	0.12%	0.12%	0.13%	0.1%	0.09%	0.1%	0.1%	0.08%	-0.14%
EBITDA Growth %	0.22%	0.32%	0.19%	0.32%	-0.23%	-0.05%	0.33%	0.1%	-0.28%	-2.75%
D&A (Non-Cash Add-back)	16.47M	16.33M	16.96M	18.89M	18.64M	19.9M	26.17M	22.14M	21.78M	22.55M
EBIT	11.52M	20.54M	26.84M	39.02M	26.22M	23.39M	30.83M	40.65M	22.94M	-31.98M
Net Interest Income+	-2.56M	-1.62M	-1.94M	-4.02M	-7.21M	-5.18M	-3.62M	-3.95M	-12.27M	-16.55M
Interest Income	0	7K	41K	174K	182K	89K	65K	167K	368K	230K
Interest Expense	2.14M	1.63M	1.98M	4.2M	7.39M	5.27M	3.69M	4.12M	12.64M	16.78M
Other Income/Expense	-2.56M	-1.62M	-1.94M	-5.42M	-7.42M	-4.59M	-4.19M	-4.69M	-13M	-18.9M
Pretax Income+	8.96M	18.92M	24.85M	33.6M	18.8M	18.32M	26.75M	35.97M	10.3M	-120.46M
Pretax Margin %	0.03%	0.06%	0.07%	0.07%	0.04%	0.04%	0.05%	0.06%	0.02%	-0.22%
Income Tax+	2.01M	5.54M	4.44M	9.14M	5.2M	3.08M	8.17M	8.56M	2.78M	5.88M
Effective Tax Rate %	0.74%	0.68%	0.82%	0.72%	0.72%	0.83%	0.69%	0.76%	0.73%	1.05%
Net Income+	6.59M	12.79M	20.27M	24.2M	13.6M	15.24M	18.59M	27.4M	7.52M	-126.34M
Net Margin %	0.02%	0.04%	0.06%	0.05%	0.03%	0.03%	0.03%	0.04%	0.01%	-0.23%
Net Income Growth %	0.36%	0.94%	0.59%	0.19%	-0.44%	0.12%	0.22%	0.47%	-0.73%	-17.8%
Net Income (Continuing)	6.32M	13.02M	20.36M	24.06M	13.6M	15.24M	18.59M	27.4M	7.52M	-126.34M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	-69K	167K	254K	0	0	0	0	0	0	0
EPS (Diluted)+	0.23	0.44	0.68	0.81	0.46	0.51	0.61	0.92	0.26	-4.50
EPS Growth %	0.35%	0.91%	0.55%	0.19%	-0.43%	0.11%	0.2%	0.51%	-0.72%	-18.31%
EPS (Basic)	0.23	0.44	0.70	0.83	0.47	0.52	0.62	0.94	0.27	-4.50
Diluted Shares Outstanding	29.24M	29.39M	29.7M	30.05M	29.66M	29.99M	30.41M	29.87M	28.53M	28.06M
Basic Shares Outstanding	28.67M	28.86M	29.1M	29.33M	29.03M	29.45M	29.81M	29.23M	28.13M	28.06M
Dividend Payout Ratio	0.17%	0.05%	0.08%	0.09%	0.17%	0.08%	0.13%	0.1%	0.45%	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	236.83M	227.07M	254.88M	310.19M	336.2M	330.25M	342M	388.57M	432.02M	378.89M
Cash & Short-Term Investments	5.52M	7.87M	11.34M	6.17M	6.58M	15.92M	16.29M	20.33M	11.42M	12.51M
Cash Only	5.52M	7.87M	11.34M	6.17M	6.58M	15.92M	16.29M	20.33M	11.42M	12.51M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	75.39M	87.21M	109.61M	134.03M	155.85M	131.75M	158.92M	168.2M	194.79M	179.47M
Days Sales Outstanding	95.09	101.98	112.68	107.69	121.5	104.84	104.01	100.71	122.72	119.69
Inventory	136.48M	120.58M	123.12M	159.9M	163.31M	163.78M	154.31M	184.19M	219.55M	179.29M
Days Inventory Outstanding	280.67	239.41	216.42	214.85	204.96	208.94	145.55	182.56	200.24	153.26
Other Current Assets	0	0	0	0	0	8.29M	0	0	0	0
Total Non-Current Assets+	206.71M	202.88M	280.71M	283.4M	354.89M	350.04M	352.16M	337.75M	335.53M	257.83M
Property, Plant & Equipment	47.97M	50.3M	49.32M	49.25M	67.78M	77.58M	91.5M	95.16M	96.98M	77.9M
Fixed Asset Turnover	6.03x	6.21x	7.20x	9.22x	6.91x	5.91x	6.10x	6.41x	5.97x	7.03x
Goodwill	0	0	22.18M	25.79M	46.56M	52.11M	46.26M	47.01M	51.2M	19.7M
Intangible Assets	129.16M	121.43M	180.95M	186.58M	198.38M	197.51M	197.84M	184.66M	172.51M	150.5M
Long-Term Investments	-8.1M	-6.71M	-16.28M	-16.01M	0	1.91M	4.4M	0	0	0
Other Non-Current Assets	29.58M	31.15M	28.25M	21.77M	21.19M	20.93M	11.89M	10.77M	14.84M	8.48M
Total Assets+	443.54M	429.96M	535.59M	593.59M	691.09M	680.29M	694.16M	726.31M	767.55M	636.72M
Asset Turnover	0.65x	0.73x	0.66x	0.77x	0.68x	0.67x	0.80x	0.84x	0.75x	0.86x
Asset Growth %	-0.06%	-0.03%	0.25%	0.11%	0.16%	-0.02%	0.02%	0.05%	0.06%	-0.17%
Total Current Liabilities+	76.28M	97.07M	126.2M	145.53M	138.64M	171.32M	223.06M	266.6M	230.5M	232.35M
Accounts Payable	15.34M	24.36M	53.75M	66.53M	64.88M	59.25M	67.14M	69M	68.83M	69.16M
Days Payables Outstanding	31.55	48.36	94.47	89.4	81.43	75.59	63.33	68.39	62.78	59.12
Short-Term Debt	55K	0	0	0	4.9M	0	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	0	1000K	1000K	1000K	1000K
Other Current Liabilities	514K	26K	5.39M	1.61M	62.03M	46.26M	802K	0	0	0
Current Ratio	3.10x	2.34x	2.02x	2.13x	2.43x	1.93x	1.53x	1.46x	1.87x	1.63x
Quick Ratio	1.32x	1.10x	1.04x	1.03x	1.25x	0.97x	0.84x	0.77x	0.92x	0.86x
Cash Conversion Cycle	344.21	293.03	234.62	233.14	245.03	238.19	186.23	214.88	260.18	213.83
Total Non-Current Liabilities+	98.93M	50.52M	104.08M	118.83M	208.29M	148.23M	98.36M	89.73M	167.04M	171.26M
Long-Term Debt	68.32M	40.95M	77.49M	96.67M	148.77M	107.44M	52.24M	51.48M	138.9M	147.33M
Capital Lease Obligations	0	0	0	0	6.5M	8.18M	20.78M	19.49M	17.11M	14.34M
Deferred Tax Liabilities	27.56M	6.71M	16.28M	15.36M	40.13M	0	20.01M	14.6M	7.89M	7.99M
Other Non-Current Liabilities	3.05M	2.87M	10.31M	6.79M	12.89M	32.61M	5.33M	4.17M	3.14M	1.6M
Total Liabilities	175.21M	147.6M	230.28M	264.36M	346.93M	319.56M	321.42M	356.33M	397.54M	403.61M
Total Debt+	68.38M	40.95M	77.49M	96.67M	160.17M	119.81M	78.08M	76.25M	162.09M	167.81M
Net Debt	62.85M	33.08M	66.15M	90.5M	153.59M	103.88M	61.79M	55.92M	150.68M	155.29M
Debt / Equity	0.25x	0.15x	0.25x	0.29x	0.47x	0.33x	0.21x	0.21x	0.44x	0.72x
Debt / EBITDA	2.44x	1.11x	1.77x	1.67x	3.57x	2.80x	1.37x	1.21x	3.60x	-
Net Debt / EBITDA	2.24x	0.90x	1.51x	1.56x	3.42x	2.43x	1.08x	0.89x	3.34x	-
Interest Coverage	5.40x	12.60x	13.52x	9.30x	3.55x	4.35x	8.39x	9.86x	1.84x	-6.05x
Total Equity+	268.33M	282.36M	305.31M	329.23M	344.16M	360.74M	372.74M	369.98M	370.01M	233.11M
Equity Growth %	0.03%	0.05%	0.08%	0.08%	0.05%	0.05%	0.03%	-0.01%	0%	-0.37%
Book Value per Share	9.18	9.61	10.28	10.96	11.60	12.03	12.26	12.39	12.97	8.31
Total Shareholders' Equity	268.39M	282.19M	305.06M	329.23M	344.16M	360.74M	372.74M	369.98M	370.01M	233.11M
Common Stock	3.16M	3.18M	3.23M	3.28M	3.32M	3.39M	3.43M	3.44M	3.47M	3.48M
Retained Earnings	208.51M	220.43M	238.95M	262.84M	274.12M	288.18M	304.38M	328.75M	332.9M	204.88M
Treasury Stock	-8.27M	-8.27M	-8.27M	-15.56M	-18.16M	-18.16M	-22.74M	-55.66M	-71.2M	-71.2M
Accumulated OCI	-3.54M	-4.85M	-4.51M	-4.51M	-5.7M	-9.32M	-13.78M	-12.18M	-5.96M	-18.73M
Minority Interest	-69K	167K	254K	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	78.57M	46.41M	59M	11.35M	9.61M	90.32M	86.36M	57.1M	-58.75M	3.92M
Operating CF Margin %	0.27%	0.15%	0.17%	0.02%	0.02%	0.2%	0.15%	0.09%	-0.1%	0.01%
Operating CF Growth %	3.3%	-0.41%	0.27%	-0.81%	-0.15%	8.4%	-0.04%	-0.34%	-2.03%	1.07%
Net Income	6.32M	13.02M	20.36M	24.06M	13.6M	15.24M	18.59M	27.4M	7.52M	-126.34M
Depreciation & Amortization	16.47M	16.33M	16.96M	18.89M	18.64M	19.9M	26.17M	22.14M	21.78M	22.32M
Stock-Based Compensation	3.88M	3.17M	4.71M	5.8M	7.16M	6.56M	6.88M	5.68M	6.14M	4.41M
Deferred Taxes	27K	-151K	398K	-561K	2.88M	-1.12M	-3.87M	-6.72M	-10.22M	-95K
Other Non-Cash Items	6.03M	5.48M	5.38M	5.63M	1.68M	105K	2.19M	6.68M	3.98M	55.62M
Working Capital Changes	45.84M	8.56M	11.19M	-42.48M	-34.35M	49.64M	36.41M	1.92M	-87.94M	48.01M
Change in Receivables	13.03M	-11.82M	754K	-21.32M	-18.37M	15.12M	-18.3M	-11.36M	-16.71M	3.71M
Change in Inventory	29.15M	15.9M	16.18M	-31.44M	3.82M	6.68M	9.36M	-29.22M	-27.32M	35.18M
Change in Payables	-5.07M	9.02M	3.32M	9.1M	-7.91M	-8.2M	8.78M	1.7M	-2.29M	3.71M
Cash from Investing+	-43.69M	-14.14M	-89.51M	-27.7M	-54.84M	-35.8M	-20.04M	-14.47M	-17.02M	-6.62M
Capital Expenditures	-43.57M	-10.85M	-88.56M	-27.7M	-16.86M	-15.26M	-10.04M	-14.55M	-12.06M	-7.69M
CapEx % of Revenue	0.15%	0.03%	0.25%	0.06%	0.04%	0.03%	0.02%	0.02%	0.02%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-36.79M	-3.51M	-6.67M	0	0	-1.19M	0	84K	242K	1.06M
Cash from Financing+	-32.86M	-28.55M	33.94M	11.13M	46.41M	-44.44M	-65.87M	-38.26M	66.74M	4.54M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-1.14M	-578K	-1.6M	-2.2M	-2.32M	-1.17M	-2.38M	-2.79M	-3.38M	-2.51M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-1.52M	-367K	-1.49M	-73K	-170K	1.1M	-386K	1.6M	1.03M	51K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	35M	35.55M	-29.56M	-16.35M	-7.25M	75.06M	76.32M	42.55M	-70.81M	-3.77M
FCF Margin %	0.12%	0.11%	-0.08%	-0.04%	-0.02%	0.16%	0.14%	0.07%	-0.12%	-0.01%
FCF Growth %	1.85%	0.02%	-1.83%	0.45%	0.56%	11.35%	0.02%	-0.44%	-2.66%	0.95%
FCF per Share	1.20	1.21	-1.00	-0.54	-0.24	2.50	2.51	1.42	-2.48	-0.13
FCF Conversion (FCF/Net Income)	11.92x	3.63x	2.91x	0.47x	0.71x	5.93x	4.65x	2.08x	-7.81x	-0.03x
Interest Paid	2.75M	1.75M	1.5M	3.32M	7.12M	5.31M	3.52M	3.83M	11.9M	15.59M
Taxes Paid	3.7M	4.95M	17.84M	-8.45M	9.28M	3.88M	5.8M	19.96M	9.43M	8.76M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	2.49%	4.64%	6.9%	7.63%	4.04%	4.32%	5.07%	7.38%	2.03%	-41.9%
Return on Invested Capital (ROIC)	2.52%	4.76%	5.85%	7.4%	4.29%	3.57%	5.16%	7.09%	3.69%	-16.76%
Gross Margin	38.67%	41.1%	41.51%	40.2%	37.88%	37.63%	30.61%	39.59%	30.92%	21.98%
Net Margin	2.28%	4.1%	5.71%	5.33%	2.9%	3.32%	3.33%	4.5%	1.3%	-23.08%
Debt / Equity	0.25x	0.15x	0.25x	0.29x	0.47x	0.33x	0.21x	0.21x	0.44x	0.72x
Interest Coverage	5.40x	12.60x	13.52x	9.30x	3.55x	4.35x	8.39x	9.86x	1.84x	-6.05x
FCF Conversion	11.92x	3.63x	2.91x	0.47x	0.71x	5.93x	4.65x	2.08x	-7.81x	-0.03x
Revenue Growth	-3.1%	7.85%	13.76%	27.95%	3.06%	-2.03%	21.58%	9.31%	-4.96%	-5.53%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
U S Crop	-	-	-	-	-	223.17M	263.63M	288.62M	269.23M	228.33M
U S Crop Growth	-	-	-	-	-	-	18.13%	9.48%	-6.72%	-15.19%
U S Non Crop	-	-	-	-	-	48.56M	78.61M	76.71M	75.29M	82.4M
U S Non Crop Growth	-	-	-	-	-	-	61.88%	-2.41%	-1.85%	9.45%
Crop	-	-	301.41M	-	402.4M	-	-	-	-	-
Crop Growth	-	-	-	-	-	-	-	-	-	-
Amount Of Herbicides Sold	111.9M	123.54M	121.58M	-	181.69M	-	-	-	-	-
Amount Of Herbicides Sold Growth	-	10.41%	-1.59%	-	-	-	-	-	-	-
Amount Of Insecticides Sold	117.18M	119.23M	132.14M	-	153.45M	-	-	-	-	-
Amount Of Insecticides Sold Growth	-	1.75%	10.83%	-	-	-	-	-	-	-
Other Including Plant Growth Regulators	-	-	47.69M	58.36M	67.27M	-	-	-	-	-
Other Including Plant Growth Regulators Growth	-	-	-	22.37%	15.26%	-	-	-	-	-
Non Crop	-	-	53.64M	61.97M	65.79M	-	-	-	-	-
Non Crop Growth	-	-	-	15.53%	6.16%	-	-	-	-	-
All Others	-	29.44M	-	-	-	-	-	-	-	-
All Others Growth	-	-	-	-	-	-	-	-	-	-
Others	29.01M	-	-	-	-	-	-	-	-	-
Others Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Non-US	-	-	-	-	-	-	-	244.28M	234.85M	236.58M
Non-US Growth	-	-	-	-	-	-	-	-	-3.86%	0.73%
Central And South America	-	16.23M	25.75M	86.17M	111.11M	102.28M	108.97M	124.53M	117.73M	118.16M
Central And South America Growth	-	-	58.61%	234.67%	28.94%	-7.94%	6.54%	14.27%	-5.46%	0.37%
MEXICO	17.1M	16.69M	16.03M	24.58M	28.84M	33.52M	40.72M	45.99M	49.8M	48.46M
MEXICO Growth	-	-2.37%	-3.95%	53.33%	17.32%	16.24%	21.50%	12.94%	8.27%	-2.68%
Asia	13.85M	17.14M	28.88M	14.83M	15.55M	19.29M	26.23M	26.59M	28.07M	34.12M
Asia Growth	-	23.77%	68.51%	-48.66%	4.90%	24.02%	36.00%	1.35%	5.58%	21.56%
AUSTRALIA	4.16M	3.73M	4.33M	2.63M	2.8M	9.9M	20.26M	19.67M	19.71M	21.69M
AUSTRALIA Growth	-	-10.17%	16.04%	-39.20%	6.19%	253.90%	104.57%	-2.88%	0.19%	10.02%
CANADA	1.58M	3.69M	4.08M	3.4M	11.64M	10.57M	10.38M	14.86M	12.27M	8.51M
CANADA Growth	-	132.81%	10.65%	-16.65%	241.96%	-9.15%	-1.84%	43.20%	-17.44%	-30.61%
Africa	8.62M	7.11M	7.89M	8.03M	6.75M	6.07M	3.47M	8.84M	3.71M	5.65M
Africa Growth	-	-17.52%	11.00%	1.70%	-15.91%	-10.04%	-42.89%	154.90%	-57.98%	51.98%
Europe	12.35M	14.52M	10.7M	11.06M	6.89M	2.29M	2.24M	1.96M	2.21M	1.89M
Europe Growth	-	17.56%	-26.30%	3.36%	-37.71%	-66.73%	-2.14%	-12.44%	12.42%	-14.27%
Middle East	3.23M	4.04M	1.24M	3.26M	2.39M	3.05M	2.36M	1.84M	1.35M	739K
Middle East Growth	-	25.11%	-69.39%	163.22%	-26.54%	27.68%	-22.82%	-22.10%	-26.25%	-45.42%
Non Us	-	83.26M	98.91M	-	185.96M	186.98M	214.63M	-	-	-
Non Us Growth	-	-	18.79%	-	-	0.55%	14.79%	-	-	-
Other Countries	437K	101K	-	-	-	-	-	-	-	-
Other Countries Growth	-	-76.89%	-	-	-	-	-	-	-	-
Central and South America	15.97M	-	-	-	-	-	-	-	-	-
Central and South America Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

American Vanguard Corporation (AVD) reported $530.1M in revenue for fiscal year 2024. This represents a 74% increase from $304.4M in 2011.

American Vanguard Corporation (AVD) saw revenue decline by 5.5% over the past year.

American Vanguard Corporation (AVD) reported a net loss of $112.1M for fiscal year 2024.

Dividend & Returns

Yes, American Vanguard Corporation (AVD) pays a dividend with a yield of 2.08%. This makes it attractive for income-focused investors.

American Vanguard Corporation (AVD) has a return on equity (ROE) of -41.9%. Negative ROE indicates the company is unprofitable.

American Vanguard Corporation (AVD) generated $2.9M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.